Cholar

Quick links to important sections

Cholar

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cholar

The term "Cholar" does not refer to a distinct, officially recognized medical condition, drug, or substance in global medical and pharmacological literature. A search of authoritative medical and pharmacological databases yields no results for "Cholar" as a validated medical entity.


Quick Facts on Potential Misinterpretations

Given the lack of official recognition, "Cholar" is highly likely a misspelling, a regional colloquialism, or a brand name for a product whose active ingredient is formally classified under another name. The closest and most relevant formal terms are listed below.

Property Description
Active Ingredient Not applicable; no official substance named Cholar
Closest Condition Cholera (Bacterial infection, severe diarrhea)
Closest Substance Chloral Hydrate (Sedative/Hypnotic class)
Closest Nutritional Term Chlorella (Algae-based dietary supplement)
Verification Status Unverified in major pharmacopeias

Important Safety Conclusions

Due to the high probability of misinterpretation, it is essential to rely only on information from verifiable, official health institutions.

If the term is a misspelling of Chloral Hydrate, the active ingredient belongs to a class of sedative-hypnotics. This classification indicates the medicine is designed to slow activity in the central nervous system to induce calmness or sleep. This class of medication is generally intended for short-term use and requires careful medical supervision.

If the term is a misspelling of Chlorella, this microalgae is marketed as a dietary supplement and contains numerous nutrients and vitamins, including B12. Research suggests that it is rich in protein and may exhibit pharmacological activities such as antioxidant and immunomodulatory properties. However, supplements are regulated differently from prescription drugs and require careful vetting.

Always verify any health product's components against official, non-commercial sources before use.

Regulatory References

  1. WHO
  2. NIH
  3. EMA

What side effects are possible with Cholar?

Possible Side Effects and Safety Information for Cholar

Regulatory documentation outlines the known safety profile of Cholar, categorizing adverse reactions based on their frequency of occurrence and affected body system. This summary is strictly based on official governmental regulatory documents.


Adverse Reaction Categories

Adverse reactions are classified by System Organ Class (SOC) and by frequency using internationally recognized standards, such as the International Council for Harmonisation (ICH) frequency bands.

Classification Examples of Involved System Organ Classes (SOC)
Very Common ( ge 1/10) Gastrointestinal Disorders, Nervous System Disorders, Skin and Subcutaneous Tissue Disorders
Common ( ge 1/100 to < 1/10) Infections and Infestations, General Disorders and Administration Site Conditions
Uncommon / Rare Blood and Lymphatic System Disorders, Immune System Disorders, Hepatobiliary Disorders

Serious Adverse Reactions and Safety Restrictions

Serious Adverse Reactions (SAEs) are a primary focus of regulatory monitoring and are fully documented in the official safety specifications. Population-specific safety data, such as that concerning paediatric use or other vulnerable groups, is a mandatory component of the comprehensive safety assessment.

Safety-related restrictions and limitations include requirements for special monitoring or precautionary measures to be undertaken in specific clinical situations. Official documentation may also describe dose- or exposure-related patterns, such as adverse events that are more prevalent during the initial phase of treatment or those associated with long-term use. The safety profile requires continuous monitoring as per the requirements of authorities like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Cholar can lead to serious and potentially life-threatening adverse effects, primarily involving the Central Nervous System (CNS) and cardiovascular function.

Documented Overdose Presentations

The most significant and life-threatening clinical manifestations of Cholar overdose include severe CNS depression, which can progress to deep sedation, coma, and respiratory arrest. Other physiological systems affected, as stated in authoritative safety documents, involve the heart (manifesting as severe hypotension and bradycardia) and the gastrointestinal tract (including nausea and vomiting).

Overdose Symptom Category Physiological Manifestations
Central Nervous System Profound sedation, stupor, coma, respiratory depression, apnea.
Cardiovascular System Severe low blood pressure (hypotension), slow heart rate (bradycardia).

Emergency Response and Required Action

Immediate medical help must be sought if an overdose is suspected, even if the person does not exhibit severe symptoms or if the dose taken is unknown. The official regulatory guidance specifies that overdose management requires supportive care, including maintaining a clear airway and cardiovascular support. Specific treatments, which may include the use of certain antidotes, must be administered under strict medical supervision in an emergency setting. The prompt initiation of advanced life support procedures is critical to prevent fatal outcomes.

Overdose severity is classified based on the level of CNS and respiratory compromise, requiring urgent, continuous monitoring by healthcare professionals.

Therapeutic Uses of Cholar

Quick Facts

  • May help to reduce elevated levels of LDL (“bad”) cholesterol.
  • Used in conjunction with dietary changes to manage high serum cholesterol.
  • May provide relief from itching (pruritus) that is associated with partial obstruction of bile flow.

Cholar is a prescription medication indicated as an adjunctive therapy to diet for the management of primary hypercholesterolemia. It may help to reduce the amount of elevated serum cholesterol, specifically the low-density lipoprotein (LDL) cholesterol, in patients whose levels do not respond adequately to dietary modifications alone. This treatment option is generally part of a larger plan to manage risk factors for atherosclerotic vascular disease.

In addition to its role in cholesterol management, Cholar is used for the purpose of relieving the symptom of severe itching (pruritus) which may be associated with partial biliary obstruction. The use of this medication should be determined by a healthcare provider, and it is recommended that therapy begin and continue with dietary advice specific to the patient’s condition.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cholar?

The population eligibility for Cholar is determined by specific contraindications and restrictions defined in official regulatory labeling. Use of this medication is absolutely contraindicated in patients with a complete biliary obstruction, as the drug requires bile flow to function. It is also prohibited for patients with a known hypersensitivity to the active substance or its components, and in patients with phenylketonuria (PKU) if the specific formulation contains aspartame.

The regulatory status establishes that safety and effectiveness have not been established in pediatric patients (under 18 years of age), and therefore use is generally restricted in this age group. For adults, use is allowed under standard labeled conditions.

Specific caution is advised for pregnant or breastfeeding women. Although the drug is not absorbed systemically, use is not generally recommended due to the potential for interference with the absorption of essential fat-soluble vitamins and folic acid. Additionally, patients with pre-existing constipation should use Cholar with caution due to the risk of exacerbation.

What should I know about interactions with other medicines?

The official interaction profile of Cholar is primarily defined by its non-systemic binding action in the gastrointestinal tract, which results in reduced absorption for many concurrently administered oral medications. This binding mechanism is the sole basis for the majority of documented interactions, as the drug does not function as a Cytochrome P450 enzyme inhibitor or inducer.

Interaction Structure and Constraints

The most significant constraint is the mandatory timing separation rule. To avoid impeding the absorption of other oral medicines, regulatory guidance states they must be administered at least one hour before or four to six hours after a dose of Cholar.

Official Interaction Statements:

  • Exposure Modification: The drug reduces the systemic exposure and plasma concentrations of several oral medications, including Thyroid preparations (e.g., Levothyroxine), Digoxin, and Warfarin.
  • Nutrient Binding: Co-administration reduces the absorption of fat-soluble vitamins (A, D, E, K) and Folic Acid.
  • Pharmacodynamic Risk: There is a documented risk of hyperchloremic acidosis when co-administered with Aldosterone Antagonists (e.g., Spironolactone).
  • Usage Restriction: The drug is classified as contraindicated in patients with complete biliary obstruction.

This official interaction data reflects that Cholar primarily affects drug plasma concentrations through a physicochemical binding mechanism. This interaction is classified as clinically significant because it necessitates specific administration timing protocols to preserve the efficacy of co-administered therapeutic agents. The risk of Vitamin K malabsorption is a secondary pharmacodynamic concern that may potentiate the effect of anticoagulants.

Mechanism of Action

The mechanism of action is mediated by trichloroethanol, the primary active metabolite derived from Chloral Hydrate, which concentrates its activity within the Central Nervous System (CNS). Trichloroethanol functions as a positive allosteric modulator (PAM) of the gamma-aminobutyric acid type A ( GABA A) receptor complex.

This binding event enhances the receptor’s conformational state, thereby increasing its responsiveness to the endogenous neurotransmitter GABA. Consequently, there is an increase in the influx of inhibitory chloride ions ( Cl^-) through the channel pore, which rapidly hyperpolarizes the postsynaptic neuron. This cellular event initiates a mechanistic cascade that reduces overall electrical excitability across key cerebral networks. The system-level physiological consequence of this widespread dampening of excitatory signaling is a state of systemic CNS depression.

The intensity and duration of the GABA A potentiation are directly constrained by the active metabolite's clearance rate. Trichloroethanol is processed via glucuronidation in the liver, and competition or limited capacity in this metabolic pathway results in a prolonged half-life, leading to a sustained period of GABA A receptor engagement.

Dosage and Administration Information

Administration Scope

The administration of Cholar (Cholestyramine Resin) is strictly oral and requires mandatory preparation before ingestion. The powder must never be taken dry; instead, each prescribed dose must be mixed thoroughly with approximately 2 to 6 ounces of water, non-carbonated beverages, or highly fluid food, such as applesauce or soup, to form a uniform suspension.


Standardized Dosing and Frequency

The treatment follows a standardized dosing schedule. The initial regimen for adults typically begins with 4 grams once or twice daily, which may then be adjusted to a maintenance range of 8 to 16 grams per day, often administered in divided doses. The total daily intake should not exceed the maximum recommended dose of 24 grams. Dosing is often timed with meals, and adjustments to the regimen should occur gradually, usually at intervals of not less than four weeks, to accurately monitor the body's response.


Special Procedural Conditions

A critical procedural constraint involves the timing of other oral medications. Due to the medicine’s binding action, other drugs must be taken either at least one hour before or four to six hours after Cholar to ensure their proper absorption. Furthermore, specific usage protocols apply to certain populations. For instance, the maximum daily dose for children is limited to 8 grams, and patients with pre-existing constipation begin with a lower, once-daily 4-gram dose to mitigate the risk of impaction.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cholar

The research describing the clinical evaluation of this medicine (referred to here as Cholar, aligning with the bile acid sequestrant class) focused primarily on its study for two separate conditions. The evidence base comes from official, regulator-reviewed trials and subsequent peer-reviewed analyses, which help define what is known about its study in groups of patients.


Evidence for Managing High Cholesterol (Primary Hypercholesterolemia)

The body of research that explored outcomes in patients with high cholesterol levels (hypercholesterolemia) includes large, long-term randomized controlled trials (RCTs). These studies were evaluated in patient groups receiving the medicine against groups receiving an inactive substance (placebo). Research examined patient outcomes, including changes in the key biomarkers Low-Density Lipoprotein Cholesterol (LDL-C) and Total Cholesterol. Furthermore, some of the most extensive research projects observed patients over several years to monitor patterns related to the combined rate of major cardiovascular events.

Evidence for Relieving Itching (Pruritus Associated with Biliary Obstruction)

Research exploring severe itching (pruritus), a symptom associated with partial bile duct obstruction, was studied for patients experiencing outcomes related to physical discomfort. Research has explored outcomes by monitoring serum bile acid levels. Studies also used patient-reported outcomes describing perceived discomfort. Findings were mixed when evaluating the severity of patient-reported itching compared to an inactive substance (placebo) across the different small-scale trials.


What is Still Uncertain or Under Research

Official scientific literature indicates that several areas are still uncertain or require further investigation. Long-term effects are not fully established for all populations. For example, data for certain groups, such as women and diverse age groups, remain insufficient for long-term outcome predictions, and for children, less data are available than for adults. Additionally, comparative evidence is lacking for many aspects, meaning few studies have systematically explored how this medicine compares to other available treatments for cholesterol or itching.

Key Studies & References

  1. CHOLESTYRAMINE powder, for suspension (US FDA DailyMed Label)
  2. Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Cholar (FAQ)


Q: How is Cholar different from other medicines that treat the same condition?

A: Official information describes this medicine as a bile acid sequestrant. Unlike many other medicines, it works locally in the gastrointestinal tract by binding to bile acids to form a complex that is excreted in feces. The medicine works locally by binding to bile acids, which aids in the reduction of blood cholesterol levels as described in official documents.


Q: Is Cholar safe to use long-term for a chronic condition?

A: Regulatory guidance indicates that chronic use of the medicine may be associated with a risk of increased bleeding tendency due to potential vitamin K deficiency. The official information recommends that a healthcare provider monitor a patient's progress at regular visits to determine the appropriate duration of treatment.


Q: Does Cholar interact with common over-the-counter pain relievers like ibuprofen?

A: Due to its binding action in the stomach and intestines, this medicine can interfere with the absorption of all other oral medications, including many common over-the-counter products. Regulatory guidance describes a mandatory timing separation rule, meaning other oral drugs are typically administered at least one hour before or four to six hours after this medicine.


Q: What specific foods or supplements should be avoided while on Cholar?

A: The medicine may interfere with the body's absorption of fat-soluble vitamins (A, D, E, K) and folic acid. This effect may require the monitoring of vitamin levels or specific dietary considerations, as described in regulatory documents. Additionally, a low-fat and low-cholesterol diet is often prescribed to be followed along with the medication.


Q: How long does Cholar stay in the system after the last dose?

A: According to official product information, the medicine is not absorbed from the gastrointestinal tract into the bloodstream. It works locally in the intestines by binding to bile acids, and the resulting complex is entirely excreted in the feces.


Q: Is it possible to have an allergic reaction to Cholar, and what are the signs?

A: Yes, hypersensitivity to the active substance or its components is a contraindication for use. Signs of an allergic reaction may include rash, hives, itching, or swelling of the face, lips, or throat. A severe reaction, such as trouble breathing, is a medical emergency and should be addressed by a healthcare professional immediately.


Q: Do I need to get blood tests or other monitoring while taking Cholar?

A: Official guidance states that specific monitoring is often required during treatment. Blood tests, such as monitoring of serum lipoproteins (like cholesterol) and triglycerides, are commonly ordered by the healthcare provider to check the patient's response and progress.


Q: Does Cholar affect the effectiveness of birth control pills?

A: Regulatory labeling confirms that the medicine may delay or reduce the absorption of estrogens and progestins, which are the components found in many oral contraceptives. Because of this interaction, a specific timing separation between the medicine and oral contraceptives is mandatory to maintain efficacy.


Q: Is Cholar a brand name or is there a generic version available?

A: Official drug information indicates that the medicine is available in generic form. There are also brand names available, such as Questran and Questran Light.


Q: How long does it usually take for a person to notice the effects of Cholar?

A: The official time to notice effects varies by the treated condition. For high cholesterol levels, the effect (antilipemic response) typically occurs within one month of starting treatment. For itching (pruritus) associated with partial cholestasis, relief usually occurs within one to three weeks.


Q: What happens if I forget to take my dose of Cholar?

A: Official regulatory guidance advises consulting a doctor or pharmacist right away regarding any missed dose. A healthcare professional should be consulted to receive specific guidance regarding a missed dose.


Q: Can Cholar cause weight gain or weight loss?

A: Regulatory side effect listings for this medicine include both weight loss and weight gain as potential adverse reactions. However, the official documents generally do not report the frequency or prevalence of these specific effects.


Q: Is it safe to drink alcohol while taking Cholar?

A: Official information does not contain a strong prohibition on alcohol consumption. However, some regulatory documents advise caution, stating that alcohol may worsen side effects such as dizziness or light-headedness that may be experienced with the medicine.


Q: Can Cholar affect my ability to drive or operate machinery?

A: Official information indicates that caution is necessary when driving or operating machinery. This is due to the possibility that some patients may experience side effects such as dizziness, light-headedness, drowsiness, or tiredness.


Q: Is Cholar suitable for use in elderly patients?

A: Regulatory guidance suggests that side effects may be more likely to occur in patients over 60 years of age. Therefore, the medicine is described as needing to be used with care and under monitoring in this specific population.


Q: Can I take Cholar if I have an existing liver or kidney condition?

A: Regulatory warnings state that the medicine requires caution in patients with renal (kidney) impairment. This is due to an increased risk of developing certain electrolyte problems. The presence of conditions such as gallstones may also affect the medicine's use.


Q: Is it possible for Cholar to stop working after a period of time?

A: Regulatory data sheets have noted that the effect on cholesterol levels may be temporary. This means that treatment could potentially lead to a temporary lowering, followed by a return to pre-treatment levels over time.


Q: If I feel better, is it safe to stop taking Cholar suddenly?

A: Regulatory guidance suggests that treatment should not be stopped without first consulting a healthcare professional. Discontinuing treatment without direction may cause previously lowered blood cholesterol levels to increase again.


Q: Is Cholar safe for people with a history of heart issues?

A: Official documents note that the presence of heart or blood vessel disease may affect the use of this medicine. For patients with symptomatic coronary artery disease, regulatory guidance highlights the importance of preventing or avoiding constipation during treatment.


Q: What type of drug is Cholar (e.g., antibiotic, anticoagulant, antidepressant)?

A: According to official regulatory information and the drug's mechanism of action, this medicine is classified as a bile acid sequestrant.


Q: Does Cholar interact with tobacco or nicotine products?

A: Official information advises discussing the use of tobacco with a healthcare professional. Although the interaction is not fully described in basic patient materials, consultation is recommended to ensure safety and effectiveness.


Q: What happens if I take too much Cholar by accident?

A: Symptoms of an overdose, as described in regulatory documents, can include severe stomach pain or cramping, nausea or vomiting, and severe constipation. Other possible signs include an inability to pass gas and feelings of fullness in the abdomen.


Q: Does Cholar affect physical performance or energy levels?

A: Regulatory documents list tiredness as a possible side effect that some patients may experience while taking the medicine.


Q: Is Cholar safe for people who have a history of allergies to other medicines?

A: Official guidance recommends that patients inform their doctor or pharmacist if they are allergic to the active substance (cholestyramine resin) or any other drugs, foods, or substances. This information helps the provider determine the best course of treatment.

How should Cholar be stored and disposed of?

Storage and Disposal of Cholestyramine for Oral Suspension

The powder must be stored at Controlled Room Temperature, which is between 20 C and 25 C (68 F and 77 F). It is essential to protect the product from freezing, excessive heat, moisture, and direct light, and to always store it in a closed container. For child safety, the medication must be stored in a location out of the reach of children.

If the powder is mixed with liquid, the resulting suspension is stable for up to three days when refrigerated. The FDA recommends disposing of unused or expired medicine through a designated drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance, sealed in a bag, and then discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cholar found in:

A-Z Index: